AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 173 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $822,151 | -19.2% | 105,811 | +0.6% | 0.01% | -22.2% |
| Q2 2023 | $1,017,736 | -1.1% | 105,138 | +11.9% | 0.01% | 0.0% |
| Q1 2023 | $1,029,495 | +147.0% | 93,932 | -2.6% | 0.01% | +125.0% |
| Q4 2022 | $416,824 | -28.5% | 96,487 | +24.5% | 0.00% | -33.3% |
| Q3 2022 | $583,000 | -31.0% | 77,495 | -7.8% | 0.01% | -25.0% |
| Q2 2022 | $845,000 | -75.7% | 84,085 | -46.5% | 0.01% | -75.8% |
| Q3 2021 | $3,476,000 | +60.0% | 157,076 | -6.3% | 0.03% | +73.7% |
| Q2 2021 | $2,172,000 | -26.9% | 167,601 | -26.7% | 0.02% | -34.5% |
| Q1 2021 | $2,971,000 | -5.7% | 228,777 | +0.4% | 0.03% | -17.1% |
| Q4 2020 | $3,151,000 | +32.6% | 227,815 | +41.2% | 0.04% | 0.0% |
| Q3 2020 | $2,377,000 | -4.7% | 161,359 | +5.1% | 0.04% | +6.1% |
| Q2 2020 | $2,495,000 | +384.5% | 153,544 | +86.9% | 0.03% | +725.0% |
| Q3 2017 | $515,000 | +13.4% | 82,163 | +10.9% | 0.00% | +33.3% |
| Q2 2017 | $454,000 | – | 74,107 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 111,608 | $2,470,000 | 3.15% |
| ACT CAPITAL MANAGEMENT, LLC | 180,000 | $3,983,000 | 2.06% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 167,889 | $3,715,000 | 1.92% |
| DG Capital Management, LLC | 402,200 | $8,901,000 | 1.81% |
| NEA Management Company, LLC | 5,172,683 | $114,471,000 | 1.36% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 801,100 | $17,728,000 | 0.99% |
| Altium Capital Management LP | 144,000 | $3,187,000 | 0.84% |
| HighMark Wealth Management LLC | 50,569 | $1,119,000 | 0.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 123,500 | $2,724,000 | 0.66% |
| SEVEN EIGHT CAPITAL, LP | 288,840 | $6,392,000 | 0.62% |